WO2003002125A3 - Combination of aminosugars and cysteine or cysteine derivatives - Google Patents
Combination of aminosugars and cysteine or cysteine derivatives Download PDFInfo
- Publication number
- WO2003002125A3 WO2003002125A3 PCT/DK2002/000446 DK0200446W WO03002125A3 WO 2003002125 A3 WO2003002125 A3 WO 2003002125A3 DK 0200446 W DK0200446 W DK 0200446W WO 03002125 A3 WO03002125 A3 WO 03002125A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cysteine
- complexes
- derivatives
- aminosugars
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101038 | 2001-06-29 | ||
DKPA200101038 | 2001-06-29 | ||
DKPA200101056 | 2001-07-04 | ||
DKPA200101056 | 2001-07-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003002125A2 WO2003002125A2 (en) | 2003-01-09 |
WO2003002125A3 true WO2003002125A3 (en) | 2003-11-06 |
WO2003002125B1 WO2003002125B1 (en) | 2004-05-21 |
Family
ID=26069044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2002/000446 WO2003002125A2 (en) | 2001-06-29 | 2002-06-28 | Combination of aminosugars and cysteine or cysteine derivatives |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003002125A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232256C (en) * | 2003-03-27 | 2005-12-21 | 中国人民解放军第三军医大学 | Application of N-acetylglucosamine in The preparation of medicine for treating local injure or whole body syndrome due to self immune reaction |
US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
DE10337638A1 (en) * | 2003-08-16 | 2005-03-24 | Kirschfeld, Kuno, Prof. Dr. | Method of treating prostatitis |
EP1761550A2 (en) | 2004-05-26 | 2007-03-14 | California Institute of Technology | Small molecule stimulators of neuronal growth |
CN101547703A (en) * | 2006-10-03 | 2009-09-30 | 加林制药公司 | S-nitrosothiol compounds and related derivatives |
US8912149B1 (en) | 2007-11-28 | 2014-12-16 | California Institute Of Technology | Glycosaminoglycan mimetics |
ES2325392B1 (en) * | 2007-12-28 | 2010-06-24 | Bioiberica, S.A. | COMPOSITION FOR THE TREATMENT OF ARTROSIS. |
ITRM20080636A1 (en) | 2008-11-28 | 2010-05-29 | Univ Palermo | PROCEDURE FOR THE PRODUCTION OF FUNCTIONAL DERIVATIVES OF HYALURONIC ACID AND RELATIVE HYDROGELS. |
CN102850412B (en) * | 2012-10-12 | 2015-07-22 | 江苏澳新生物工程有限公司 | Preparation method of D-glucosamine sulfate sodium chloride salt |
US10227370B2 (en) | 2013-08-02 | 2019-03-12 | California Institute Of Technology | Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity |
US9770461B2 (en) | 2013-08-02 | 2017-09-26 | California Institute Of Technology | Tailored glycopolymers as anticoagulant heparin mimetics |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1283892A (en) * | 1970-06-08 | 1972-08-02 | Irwin Irville Lubowe | Improvements in and relating to medicinal compositions for application to the skin and/or hair |
EP0652012A1 (en) * | 1989-03-27 | 1995-05-10 | Albert Naito | Combination of sugars with animo acids and other drugs |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
WO1999055326A1 (en) * | 1998-04-30 | 1999-11-04 | Vit-Immune, L.C. | Method of treatment of glutathione deficient mammals |
WO2000007607A1 (en) * | 1998-08-04 | 2000-02-17 | Kosbab, John, V. | Nutrient and therapeutic compositions for the treatment of cancer |
WO2001013865A1 (en) * | 1999-08-20 | 2001-03-01 | Howard Murad | Pharmaceutical compositions and methods for reducing the appearance of cellulite |
US6231889B1 (en) * | 1998-09-21 | 2001-05-15 | Chronorx, Llc | Unit dosage forms for the treatment of herpes simplex |
WO2002004003A2 (en) * | 2000-07-10 | 2002-01-17 | N.V. Nutricia | Composition for the treatment of osteoarthritis |
-
2002
- 2002-06-28 WO PCT/DK2002/000446 patent/WO2003002125A2/en not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1283892A (en) * | 1970-06-08 | 1972-08-02 | Irwin Irville Lubowe | Improvements in and relating to medicinal compositions for application to the skin and/or hair |
EP0652012A1 (en) * | 1989-03-27 | 1995-05-10 | Albert Naito | Combination of sugars with animo acids and other drugs |
US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
WO1999055326A1 (en) * | 1998-04-30 | 1999-11-04 | Vit-Immune, L.C. | Method of treatment of glutathione deficient mammals |
WO2000007607A1 (en) * | 1998-08-04 | 2000-02-17 | Kosbab, John, V. | Nutrient and therapeutic compositions for the treatment of cancer |
US6231889B1 (en) * | 1998-09-21 | 2001-05-15 | Chronorx, Llc | Unit dosage forms for the treatment of herpes simplex |
WO2001013865A1 (en) * | 1999-08-20 | 2001-03-01 | Howard Murad | Pharmaceutical compositions and methods for reducing the appearance of cellulite |
WO2002004003A2 (en) * | 2000-07-10 | 2002-01-17 | N.V. Nutricia | Composition for the treatment of osteoarthritis |
Also Published As
Publication number | Publication date |
---|---|
WO2003002125B1 (en) | 2004-05-21 |
WO2003002125A2 (en) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2903300A (en) | Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing medicament or a dietary supplement for thetreatment or prevention of inflammation, hypersensitivity reactions or pain | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
WO2006014673A3 (en) | Insulin-oligomer conjugates, formulations and uses thereof | |
AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
MX9605940A (en) | Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization. | |
WO2008058547A3 (en) | Alpha-lactalbumin composition | |
CA2282082A1 (en) | Microgranules containing cisplatin | |
AU2002351583A1 (en) | Chitosan oligosaccharides and uses thereof | |
WO2003002125A3 (en) | Combination of aminosugars and cysteine or cysteine derivatives | |
PT1200106E (en) | COMPOSITION CONTAINING BUTYROSPERMUM PARKII EXTRACTS AND USES AS A MEDICATION OR DIETETIC SUPPLEMENT | |
HUP0304077A2 (en) | Pharmaceutical and cosmetic compositions against skin aging | |
AU5634500A (en) | Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
WO2003002117A3 (en) | Niaciamide and derivatives in combination with aminosugar | |
WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption | |
PL367812A1 (en) | Alpha-ketoglutarates of active ingredients and compositions containing same | |
WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
JP4584453B2 (en) | Composition comprising a mixture of bioflavonol | |
EP1232748A4 (en) | Substituted nitrobenzene derivatives as medicines and other useful uses thereof | |
BR0313789A (en) | Drug containing disorazoles and their derivatives for the treatment of malignant and benign tumoral diseases. | |
WO2001093832A3 (en) | Aqueous chondroprotective compositions having defined dosage requirements for efficacious delivery | |
CA2321265A1 (en) | Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
B | Later publication of amended claims |
Effective date: 20021213 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |